You are here

diabetes

Eli Lilly settles Minnesota lawsuit over insulin pricing

Reuters

Wed, 02/7/24 - 11:19 am

Fractyl Breaks the Medical Device IPO Drought with New Offering

Medical Devices and Diagnostics Industry

Sun, 02/4/24 - 12:37 pm

Will Novo Nordisk Be a $1 Trillion Company by 2030?

Motley Fool

Tue, 01/30/24 - 10:40 am

Lilly's weight-loss drug Mounjaro coming to UK after pen cleared

Reuters

Thu, 01/25/24 - 09:00 pm

7 JPM Announcements You Don’t Want to Miss

MedCity News

Fri, 01/12/24 - 09:51 am

Boston Scientfic

artificial intelligence

JPM24: ‘Diabesity’ duopoly between Novo, Lilly takes center stage

Medical Marketing and Media

Thu, 01/11/24 - 11:18 am

Abbott CEO Touts Libre as ‘Most Successful Medtech Product in History’

Medical Devices and Diagnostics Industry

Wed, 01/10/24 - 06:21 pm

FreeStyle Libre

FDA warns about counterfeit versions of Novo's diabetes drug Ozempic

Reuters

Fri, 12/22/23 - 09:40 am

drug counterfeiting

Structure shares sink as obesity pill misses expectations in small study

BioPharma Dive

Mon, 12/18/23 - 10:17 pm

Structure Therapeutics

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

Tue, 11/21/23 - 10:54 pm

Beyond insulin: Medical expands patient access to diabetes supplies

Medical Marketing and Media

Sun, 11/19/23 - 09:34 pm

Novo Nordisk sets aside $6bn to boost production capacity

Pharmaphorum

Fri, 11/10/23 - 10:11 am

drug manufacturing

Novo Nordisk to discontinue Levemir insulin in U.S. market

Reuters

Wed, 11/8/23 - 09:59 pm

An obesity drug biotech gets buy-in from Eli Lilly, venture firms

BioPharma Dive

Tue, 11/7/23 - 09:50 am

Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.

Motley Fool

Wed, 10/25/23 - 09:51 am

Belgium plans temporary ban on use of Ozempic for weight loss

Yahoo/Reuters

Tue, 10/24/23 - 09:39 am

Insulet Omnipod 5 iPhone App FDA Cleared

Medical Devices and Diagnostics Industry

Mon, 10/23/23 - 05:09 pm

insulin delivery

Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral

Yahoo/Reuters

Thu, 10/12/23 - 05:24 pm

Fresenius Medical Care

Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals

BioSpace

Wed, 10/11/23 - 10:15 am

clinical trials

chronic kidney disease

Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch

Forbes

Tue, 10/10/23 - 11:55 pm

Pages